Sanofi-aventis wraps up tender offer for Chattem
Sanofi-aventis has completed its tender offer for all outstanding shares of common stock of Chattem Inc. under its $1.9 billion deal to acquire the U.S. drug maker. The Paris-based pharmaceutical giant said Tuesday that as of the tender offer’s expiration on Feb.